Current Treatment Options in Cardiovascular Medicine最新文献

筛选
英文 中文
The Role of Home-Based Exercise in the Management of Peripheral Artery Disease. 居家锻炼在外周动脉疾病管理中的作用
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2026-12-01 Epub Date: 2026-04-27 DOI: 10.1007/s11936-026-01143-4
Carlos A Ortega, Aaron W Aday, Tara A Holder, Brian R Lindman, Alexander E Sullivan
{"title":"The Role of Home-Based Exercise in the Management of Peripheral Artery Disease.","authors":"Carlos A Ortega, Aaron W Aday, Tara A Holder, Brian R Lindman, Alexander E Sullivan","doi":"10.1007/s11936-026-01143-4","DOIUrl":"10.1007/s11936-026-01143-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>Supervised-exercise therapy (SET) is a cornerstone intervention for management of peripheral artery disease (PAD) and is associated with improvement in ambulatory functional status. Despite strong evidence supporting the benefits of SET, accessibility and adherence remains a challenge, underling its full clinical potential. Home-based exercise therapy (HBET) has emerged as more accessible alternative to SET. This paper reviews the benefits of exercise in PAD, explores the role of home-based exercise therapy in the management of PAD, and describes the essential components of HBET in contemporary clinical practice.</p><p><strong>Recent findings: </strong>HBET programs have demonstrated similar improvements in ambulatory function, including walking distance and pain-free walking distance, as established SET regimens. Recent clinical trials and meta-analysis have established HBET as a reasonable alternative to SET, as reflected in the latest multi-societal clinical guidelines.</p><p><strong>Summary: </strong>Functional and quality of life improvements with HBET parallel those with SET and outperform routine exercise education. Successful HBET should include both monitoring and behavioral intervention components to improve adherence and long-term symptomatic improvements. Providers should tailor HBET to the individual patient's needs and limitations. Ongoing research aims to understand the optimal platform to deliver HBET programs to a wide range of patients with symptomatic PAD.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"28 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13533404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148876023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise and Sport Participation in Pediatric Hypertrophic Cardiomyopathy: A Changing Paradigm. 儿童肥厚性心肌病的运动和运动参与:一个变化的范例。
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2026-01-01 Epub Date: 2026-08-03 DOI: 10.1007/s11936-026-01150-5
William W Russell, Jonathan B Edelson
{"title":"Exercise and Sport Participation in Pediatric Hypertrophic Cardiomyopathy: A Changing Paradigm.","authors":"William W Russell, Jonathan B Edelson","doi":"10.1007/s11936-026-01150-5","DOIUrl":"10.1007/s11936-026-01150-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review aims to detail recent research and guidelines that have changed the approach to exercise and sport participation in the pediatric hypertrophic cardiomyopathy (HCM) population.</p><p><strong>Recent findings: </strong>Recent studies, including the landmark LIVE-HCM cohort, demonstrated that vigorous exercise was not associated with death, implantable cardiac defibrillator (ICD) shock, resuscitated cardiac arrest, or arrhythmic syncope in patients with HCM. Furthermore, there is increasing evidence that restriction from physical activity (PA) has negative consequences for the cardiovascular health and emotional well-being of children with HCM. This has influenced guidelines that promote individualized risk assessment and shared decision-making (SDM), rather than uniform restriction, in children with HCM who wish to participate in both recreational and competitive athletics.</p><p><strong>Summary: </strong>The relationship between PA and cardiac events in children and adults with HCM is more nuanced than once believed, and the negative consequences of uniform PA restrictions have become increasingly clear. Guided by recent prospective cohort studies, the approach to adolescents and young adults with HCM is changing, now emphasizing the role of individualized risk assessment and SDM.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"28 1","pages":"18"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13433578/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148674332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Phenotyping with Photoacoustic and Ultrasound Imaging in Cardiovascular Disease: Recent Innovations. 心血管疾病的光声和超声成像血管表型:最近的创新。
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2026-01-01 Epub Date: 2026-10-12 DOI: 10.1007/s11936-026-01162-1
Muhang He, Xiaoxi Zhuang, Rui Cao
{"title":"Vascular Phenotyping with Photoacoustic and Ultrasound Imaging in Cardiovascular Disease: Recent Innovations.","authors":"Muhang He, Xiaoxi Zhuang, Rui Cao","doi":"10.1007/s11936-026-01162-1","DOIUrl":"10.1007/s11936-026-01162-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>Photoacoustic and ultrasound imaging together resolve vascular structure, wall biomechanics, blood flow, oxygenation, and tissue composition without ionizing radiation or iodinated contrast. This review summarizes what each modality can now measure in patients and asks which of these measurements are close enough to clinical use to inform cardiovascular management decisions.</p><p><strong>Recent findings: </strong>Recent advances have expanded photoacoustic imaging toward faster, higher-resolution functional vascular phenotyping, including clinically relevant biomarkers and co-registered ultrasound imaging. Ultrafast and super-resolution ultrasound now quantify vascular biomechanics, hemodynamics, and microvasculature, with ultrasound localization microscopy entering clinical studies. Wearable ultrasound has also been validated for blood-pressure monitoring across diverse care settings, alongside increasingly quantitative feature extraction.</p><p><strong>Summary: </strong>Ultrasound and photoacoustic imaging provide complementary vascular information: ultrasound offers depth, speed, and continuous access, while photoacoustic imaging adds compositional and oxygenation contrast. Despite limitations in quantitative accuracy, imaging depth, and system standardization, emerging patient studies now span super-resolution vascular mapping, functional biomarkers, and wearable monitoring. Their integration offers a potential route toward continuous, operator-independent vascular phenotyping for clinical decision-making.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"28 1","pages":"29"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149184981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elucidating Gene Functions in Congenital Heart Disease. 阐明先天性心脏病的基因功能。
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2026-01-01 Epub Date: 2026-10-06 DOI: 10.1007/s11936-026-01157-y
Sukanya Raghu, Ankit K Tamta, Sanchita Sanchaya Dey, Mohamed Imdhiyas Abdul Basheed, Aniqua Tasnim Chowdhury, Swetansu K Hota, Nathan J VanDusen
{"title":"Elucidating Gene Functions in Congenital Heart Disease.","authors":"Sukanya Raghu, Ankit K Tamta, Sanchita Sanchaya Dey, Mohamed Imdhiyas Abdul Basheed, Aniqua Tasnim Chowdhury, Swetansu K Hota, Nathan J VanDusen","doi":"10.1007/s11936-026-01157-y","DOIUrl":"10.1007/s11936-026-01157-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Congenital heart defects (CHDs) arise from disruption of precisely orchestrated developmental programs that coordinate cardiac lineage specification, morphogenesis, maturation, and tissue remodeling. This review highlights recent advances in experimental systems used to connect CHD-associated genes and variants to developmental mechanisms.</p><p><strong>Recent findings: </strong>In vivo mouse and vertebrate studies have refined models of early cardiogenic mesoderm formation, heart-field allocation, valve development, outflow tract morphogenesis, epicardial-myocardial interactions, and ventricular compaction. Parallel work on postnatal cardiac maturation highlights how RNA processing, metabolic remodeling, immune signaling, and non-myocyte populations influence cardiomyocyte maturation and regenerative competence, with implications for long-term outcomes in CHD survivors. Human pluripotent stem cell models provide complementary platforms for investigating gene functions: two-dimensional differentiation enables scalable, temporally controlled analysis of lineage commitment and cell-autonomous phenotypes, whereas organoids and other three-dimensional models introduce spatial organization, multicellular interactions, and tissue-level readouts. Genome editing, CRISPR screening, base and prime editing, regulatory-element assays, and inducible protein-depletion systems now allow increasingly precise and high-throughput characterization of coding and noncoding variants.</p><p><strong>Summary: </strong>Together, these advances are enabling a transition in CHD research from descriptive genomics to integrated, multi-model approaches that connect genetic variation to gene function, developmental mechanisms, and disease phenotypes.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"28 1","pages":"27"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642465/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Light-Sheet Fluorescence Microscopy for Cardiac Vascular Imaging in Zebrafish. 新兴的光片荧光显微镜用于斑马鱼的心血管成像。
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2026-01-01 Epub Date: 2026-10-06 DOI: 10.1007/s11936-026-01159-w
Sakib Nazmus, Juhyun Lee
{"title":"Emerging Light-Sheet Fluorescence Microscopy for Cardiac Vascular Imaging in Zebrafish.","authors":"Sakib Nazmus, Juhyun Lee","doi":"10.1007/s11936-026-01159-w","DOIUrl":"10.1007/s11936-026-01159-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>Cardiac vascular remodeling is central to cardiovascular development, injury, and regeneration, yet it remains difficult to resolve in three dimensions within the living, beating heart. This review critically evaluates emerging light-sheet fluorescence microscopy (LSFM) strategies for zebrafish cardiac vascular studies, distinguishes directly demonstrated cardiac applications from transferable methods established in other tissues, and defines quantitative endpoints needed for rigorous treatment-response assessment.</p><p><strong>Recent findings: </strong>Cardiac-gated and four-dimensional LSFM, hybrid light-field/light-sheet imaging, multiscale acquisition, automated segmentation, and deep-learning-assisted reconstruction have enabled cardiac-cycle-resolved visualization of myocardial motion, intracardiac flow, endothelial migration, vascular remodeling, and regenerative responses. However, the evidence base is uneven: several approaches are validated directly in the zebrafish heart, whereas others remain enabling technologies whose cardiac microvascular utility is inferred from noncardiac applications.</p><p><strong>Summary: </strong>LSFM can serve as a powerful discovery platform when fluorescent reporters, motion synchronization, quantitative analysis, and biological validation are integrated prospectively. The field now requires standardized acquisition and reporting, explicit separation of measured and model-derived endpoints, validation of AI-assisted reconstructions, and coordinated confirmation in mammalian or human cardiovascular models.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"28 1","pages":"28"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice. 冠状动脉疾病药物包被气球:从理论到实践。
IF 0.6
Current Treatment Options in Cardiovascular Medicine Pub Date : 2025-12-01 Epub Date: 2025-03-19 DOI: 10.1007/s11936-025-01084-4
Mohamad B Moumneh, Yasser Jamil, Michael G Nanna, Abdulla A Damluji
{"title":"Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.","authors":"Mohamad B Moumneh, Yasser Jamil, Michael G Nanna, Abdulla A Damluji","doi":"10.1007/s11936-025-01084-4","DOIUrl":"10.1007/s11936-025-01084-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this work is to review the role of drug-coated balloons (DCBs) in contemporary coronary artery disease (CAD) management by focusing on its clinical indications and technical considerations, supported by updated insights from the International DCB Consensus Group.</p><p><strong>Recent findings: </strong>While percutaneous coronary intervention (PCI) and drug-eluting stents were initially the standard treatment for CAD, limitations such in-stent stenosis, neoatherosclerosis, and increased bleeding led to the development of the novel DCBs. These DCBs have become well established in treating various clinical cases such as in-stent restenosis, de-novo small-vessel disease, bifurcation lesions, large-vessel disease, high bleeding risk, acute coronary syndromes, and diabetes mellitus.</p><p><strong>Summary: </strong>For optimal DCB outcomes, functional assessments, careful lesion preparation, and patient selection are crucial for effective drug delivery and reduced complications. Ongoing innovations in drug formulations, balloon design, and delivery mechanisms, along with further trials, will expand DCBs' impact in CAD treatment.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"27 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12392985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Digital Revolution in Medicine: Applications in Cardio-Oncology. 医学中的数字革命:在心脏肿瘤学中的应用。
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2025-12-01 Epub Date: 2024-11-05 DOI: 10.1007/s11936-024-01059-x
Gift Echefu, Ladislav Batalik, Abdulkareem Lukan, Rushabh Shah, Priyanshu Nain, Avirup Guha, Sherry-Ann Brown
{"title":"The Digital Revolution in Medicine: Applications in Cardio-Oncology.","authors":"Gift Echefu, Ladislav Batalik, Abdulkareem Lukan, Rushabh Shah, Priyanshu Nain, Avirup Guha, Sherry-Ann Brown","doi":"10.1007/s11936-024-01059-x","DOIUrl":"10.1007/s11936-024-01059-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>A critical evaluation of contemporary literature regarding the role of big data, artificial intelligence, and digital technologies in precision cardio-oncology care and survivorship, emphasizing innovative and groundbreaking endeavors.</p><p><strong>Recent findings: </strong>Artificial intelligence (AI) algorithm models can automate the risk assessment process and augment current subjective clinical decision tools. AI, particularly machine learning (ML), can identify medically significant patterns in large data sets. Machine learning in cardio-oncology care has great potential in screening, diagnosis, monitoring, and managing cancer therapy-related cardiovascular complications. To this end, large-scale imaging data and clinical information are being leveraged in training efficient AI algorithms that may lead to effective clinical tools for caring for this vulnerable population. Telemedicine may benefit cardio-oncology patients by enhancing healthcare delivery through lowering costs, improving quality, and personalizing care. Similarly, the utilization of wearable biosensors and mobile health technology for remote monitoring holds the potential to improve cardio-oncology outcomes through early intervention and deeper clinical insight. Investigations are ongoing regarding the application of digital health tools such as telemedicine and remote monitoring devices in enhancing the functional status and recovery of cancer patients, particularly those with limited access to centralized services, by increasing physical activity levels and providing access to rehabilitation services.</p><p><strong>Summary: </strong>In recent years, advances in cancer survival have increased the prevalence of patients experiencing cancer therapy-related cardiovascular complications. Traditional cardio-oncology risk categorization largely relies on basic clinical features and physician assessment, necessitating advancements in machine learning to create objective prediction models using diverse data sources. Healthcare disparities may be perpetuated through AI algorithms in digital health technologies. In turn, this may have a detrimental effect on minority populations by limiting resource allocation. Several AI-powered innovative health tools could be leveraged to bridge the digital divide and improve access to equitable care.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"27 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11600984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142751885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Photoacoustic Imaging Techniques for Peripheral Arterial Disease. 外周动脉疾病的新兴光声成像技术。
IF 1.1
Current Treatment Options in Cardiovascular Medicine Pub Date : 2025-01-01 Epub Date: 2025-08-28 DOI: 10.1007/s11936-025-01113-2
Yide Zhang, Lihong V Wang
{"title":"Emerging Photoacoustic Imaging Techniques for Peripheral Arterial Disease.","authors":"Yide Zhang, Lihong V Wang","doi":"10.1007/s11936-025-01113-2","DOIUrl":"10.1007/s11936-025-01113-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>Photoacoustic imaging (PAI) has emerged as a promising non-ionizing modality that leverages optical absorption contrast to provide both anatomical and functional insights into vascular health. This review examines recent advances in PAI technologies applied to the diagnosis, assessment, and management of peripheral arterial disease (PAD). The goal is to evaluate how emerging PAI techniques address current diagnostic limitations and to identify opportunities for clinical integration.</p><p><strong>Recent findings: </strong>Recent studies have demonstrated the potential of PAI to capture high-resolution, dynamic images of peripheral vasculature, quantify oxygen saturation and regional blood volume, and assess microvascular health. Technological innovations, including single-shot volumetric imaging, all-optical scanners, and multimodal systems, have expanded PAI's clinical utility.</p><p><strong>Summary: </strong>Emerging PAI systems show promise for complementing traditional imaging by providing functional insights into microvascular health. Continued technological development and validation through large-scale studies are essential for establishing PAI's clinical role in PAD diagnosis and management.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"27 1","pages":"56"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracoronary Optical Coherence Tomography: Technological Innovations and Clinical Implications in Cardiology. 冠状动脉内光学相干断层扫描:技术创新和心脏病学的临床意义。
IF 0.6
Current Treatment Options in Cardiovascular Medicine Pub Date : 2025-01-01 Epub Date: 2025-07-24 DOI: 10.1007/s11936-025-01103-4
Yuchen Jiang, Jingyi Wang, Raksha Sreeramachandra Murthy, Pranav Patel, Zhongping Chen
{"title":"Intracoronary Optical Coherence Tomography: Technological Innovations and Clinical Implications in Cardiology.","authors":"Yuchen Jiang, Jingyi Wang, Raksha Sreeramachandra Murthy, Pranav Patel, Zhongping Chen","doi":"10.1007/s11936-025-01103-4","DOIUrl":"10.1007/s11936-025-01103-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>To provide the most up-to-date clinical evidence of intracoronary optical coherence tomography (OCT), and clinical implications to guide future imaging research in cardiology.</p><p><strong>Recent findings: </strong>Intracoronary OCT has demonstrated advanced system performance and high reproducibility in analyzing atherosclerotic lesions. It is an attractive tool due to its capability for functional classification and superior imaging resolution, enabling precise and reliable tissue assessments. Compared to traditional angiography, OCT has been associated with improved long-term clinical outcomes and serves as an effective tool for optimizing stent selection and post-intervention evaluation. The development of OCT variations and the combination of various intravascular imaging modalities further enhance its diagnostic capabilities, allowing a comprehensive assessment of complex vulnerable lesions and improving risk stratification for patients.</p><p><strong>Summary: </strong>Current and evolving system development presents a hopeful path for treating coronary artery disease by addressing the challenges of the intracoronary OCT technique. Future studies focusing on utilizing OCT system extensions, integrated multimodality imaging systems, and Artificial Intelligence (AI) derived image analysis will improve clinical endpoints and streamline the process.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"27 1","pages":"44"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12289833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying Responders to Transcatheter Interventions for Secondary Mitral Regurgitation. 识别经导管介入治疗继发性二尖瓣反流的应答者。
IF 0.6
Current Treatment Options in Cardiovascular Medicine Pub Date : 2025-01-01 Epub Date: 2025-07-31 DOI: 10.1007/s11936-025-01095-1
Diane Rizkallah, Carl Ammoury, Elio Haroun, Joseph El Roumi, Ben Alencherry, Rhonda Miyasaka, Amar Krishnaswamy, Samir Kapadia, Serge Harb, Deborah Kwon
{"title":"Identifying Responders to Transcatheter Interventions for Secondary Mitral Regurgitation.","authors":"Diane Rizkallah, Carl Ammoury, Elio Haroun, Joseph El Roumi, Ben Alencherry, Rhonda Miyasaka, Amar Krishnaswamy, Samir Kapadia, Serge Harb, Deborah Kwon","doi":"10.1007/s11936-025-01095-1","DOIUrl":"10.1007/s11936-025-01095-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>This article offers a comprehensive review of the literature on imaging predictors of response to transcatheter interventions for secondary mitral regurgitation (SMR).</p><p><strong>Recent findings: </strong>Recent advancements in percutaneous valve therapies have broadened treatment options for high-risk patients with SMR. While recent studies have demonstrated significant reduction in all-cause mortality and hospitalizations with transcatheter edge-to-edge repair (TEER), significant controversy remains. This review highlights the central role of multi-modality imaging to guide therapeutic decision making for optimal treatment response and long-term outcomes.</p><p><strong>Summary: </strong>Several echocardiographic, computerized tomography (CT) and cardiac magnetic resonance (CMR) imaging parameters are central to identifying optimal conditions for transcatheter therapies. Imaging features have become key predictors of outcomes following transcatheter interventions for secondary mitral regurgitation and provide important risk stratification to guide therapeutic decision making and shared decision making.</p>","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"27 1","pages":"54"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12313785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书